Verdaguer E - Search Results

1

Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment.

Busquets O, Ettcheto M, Cano A, R Manzine P, Sánchez-Lopez E, Espinosa-Jiménez T, Verdaguer E, Dario Castro-Torres R, Beas-Zarate C, X Sureda F, Olloquequi J, Auladell C, Folch J, Camins A. Busquets O, et al. Among authors: verdaguer e. Int J Mol Sci. 2019 Dec 30;21(1):255. doi: 10.3390/ijms21010255. Int J Mol Sci. 2019. PMID: 31905931 Free PMC article. Review.

2

Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis.

Jorda EG, Verdaguer E, Canudas AM, Jiménez A, Bruna A, Caelles C, Bravo R, Escubedo E, Pubill D, Camarasa J, Pallàs M, Camins A. Jorda EG, et al. Among authors: verdaguer e. Neuropharmacology. 2003 Oct;45(5):672-83. doi: 10.1016/s0028-3908(03)00204-1. Neuropharmacology. 2003. PMID: 12941380

3

Inhibition of multiple pathways accounts for the antiapoptotic effects of flavopiridol on potassium withdrawal-induced apoptosis in neurons.

Verdaguer E, Jordà EG, Alvira D, Jiménez A, Canudas AM, Folch J, Rimbau V, Pallàs M, Camins A. Verdaguer E, et al. J Mol Neurosci. 2005;26(1):71-84. doi: 10.1385/JMN:26:1:071. J Mol Neurosci. 2005. PMID: 15968087

4

Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease.

Alvira D, Tajes M, Verdaguer E, Acuña-Castroviejo D, Folch J, Camins A, Pallas M. Alvira D, et al. Among authors: verdaguer e. J Pineal Res. 2006 Apr;40(3):251-8. doi: 10.1111/j.1600-079X.2005.00308.x. J Pineal Res. 2006. PMID: 16499562

5

Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons.

Garcia de Arriba S, Wegner F, Grüner K, Verdaguer E, Pallas M, Camins A, Wagner A, Wohlfahrt K, Allgaier C. Garcia de Arriba S, et al. Among authors: verdaguer e. Neurochem Int. 2006 Oct;49(5):466-74. doi: 10.1016/j.neuint.2006.03.005. Epub 2006 May 2. Neurochem Int. 2006. PMID: 16650914

6

Involvement of calpain activation in neurodegenerative processes.

Camins A, Verdaguer E, Folch J, Pallàs M. Camins A, et al. Among authors: verdaguer e. CNS Drug Rev. 2006 Summer;12(2):135-48. doi: 10.1111/j.1527-3458.2006.00135.x. CNS Drug Rev. 2006. PMID: 16958987 Free PMC article. Review.

7

The role of CDK5/P25 formation/inhibition in neurodegeneration.

Camins A, Verdaguer E, Folch J, Canudas AM, Pallàs M. Camins A, et al. Among authors: verdaguer e. Drug News Perspect. 2006 Oct;19(8):453-60. doi: 10.1358/dnp.2006.19.8.1043961. Drug News Perspect. 2006. PMID: 17160145 Free article. Review.

8

Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis.

Verdaguer E, Susana Gde A, Clemens A, Pallàs M, Camins A. Verdaguer E, et al. Biomed Pharmacother. 2007 Aug;61(7):390-9. doi: 10.1016/j.biopha.2006.11.001. Epub 2006 Nov 29. Biomed Pharmacother. 2007. PMID: 17178208 Review.

9

Inhibition of ataxia telangiectasia-p53-E2F-1 pathway in neurons as a target for the prevention of neuronal apoptosis.

Camins A, Verdaguer E, Folch J, Beas-Zarate C, Canudas AM, Pallàs M. Camins A, et al. Among authors: verdaguer e. Curr Drug Metab. 2007 Oct;8(7):709-15. doi: 10.2174/138920007782109814. Curr Drug Metab. 2007. PMID: 17979659 Review.

10

The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes.

Pizarro JG, Yeste-Velasco M, Esparza JL, Verdaguer E, Pallàs M, Camins A, Folch J. Pizarro JG, et al. Among authors: verdaguer e. J Pineal Res. 2008 Aug;45(1):8-16. doi: 10.1111/j.1600-079X.2007.00548.x. Epub 2008 Feb 14. J Pineal Res. 2008. PMID: 18284548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page